Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

A Case Report of Efficacy of Growth Height and Peak-Luteinizing Hormone Level Suppression on Idiopathic Gonadotropin-Dependent Precocious Puberty Patient Using Herbal Remedy, Aesopjiyoun-tang

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2015, v.36 no.4, pp.147-151
(Aesop Hospital of Korean Medicine)
Chong-hai Lee1 (Aesop Hospital of Korean Medicine)
Yu-wei Tang (Aesop Clinic of Korean Medicine)
Yuan-sheng Liu (Aesop Clinic of Korean Medicine)
Ki-chul Kim (Aesop Clinic of Korean Medicine)
Sang-yeol Chun (Busan Aijoa Clinic of Korean Medicine)

Hyung chang Kim (Gamchodang-Aesop pibro Clinic of Korean Medicine)
Myoung-deok Lee (Aesop Hospital of Korean Medicine)
  • Downloaded
  • Viewed

Abstract

The purpose of this report is to evaluate effect of Korean medical treatment on idiopathic gonadotropin-dependent precocious puberty (G-DPP) patient received herbal medicine. We administered Aesopjiyoun-tang remedy to idiopathic G-DPP and analyzed the delay effect by hormonal value and radiographs; the height growth effect by measurement of height. After Korean medical treatment, suppression effect to peak- Luteinizing Hormone level (LHL) is 14.39IU/L to 10.9IU/L for 13month, growth effect to height value is 11cm/13month; and change of mean growth velocity (MGV) is 6.08cm/year to 10.06cm/year. The gain in height by treatment is 3.98cm/year. The result suggests Aesopjiyoun-tang can be an effective treatment for G-DPP. Herbal medicine can be used as an alternative treatment in place of the GnRH treatment.

keywords
Precocious puberty, Herbal medicine, Growth height, Aesopjiyoun-tang, GnRH treatment


Reference

1

1. Carel JC, Léger J. Precocious puberty. The New England journal of medicine. 2008;358:2366 77.

2

2. Martin R. Early puberty: what is normal and when is treatment indicated. Horm. Res. 2003;60 (suppl3):31-4.

3

3. Brown JJ, Warne GL. Growth in precocious puberty. Indian journal of pediatrics. 2006;73:81-88.

4

4. Gluckman PD, Hanson MA. Evolution, development and timing of puberty. Trends in endocrinology and metabolism. 2006;17(1):7-12.

5

5. Lazar L, Kauli R, Pertzelan A, Phillip M. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height. J Clin Endocrinol Metab. 2002;87:2090-4.

6

6. Kim TH, Coe HJ, Kim S et.,al. Cinical and Endocrinologic Characteristics of Children Referred for Precocious Puberty. Korean J of pediatrics. 2007;12(2):119-26.

7

7. Styne D, Grumbach M. Puberty: ontogeny, neuroendocri-nology, physiology, and disorders. In: Kronenberg HM, Mel-med S, Polonsky KS, Larsen PR, editors. Williams textbook of endocrinology. 11th ed. Philadelphia: Saunders Co. 2008:969-1166.

8

8. Heger S, Muller M, Ranke M, Schwarz HP, Waldhauser F, Partsch CJ, et al. Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function. Mol Cell Endocrinol. 2006;254-255:217-20.

9

9. Lim YK, Hur KW, Park SY, Suh KS, Chun SY, Lee SJ, Lee H, Kim H. A Case Report of Precocious Puberty in a Female Patient :Significant Improvement in Controlling the Sex Hormone Levels. J Pediatr Korean Med. 2014;28(4):64-70.

10

10. Kim JE, Yang SJ, Cho SH, Park HM. A report on the effect of jowisengchung-tang in 2 cases of precocious puberty. J Korean obstet gynecol. 2013;26(2):178-187.

11

11. Tanner JM, Healy MJR, Goldstein H. Assessment of skeletal maturity and prediction of adult height. Oxford: Elsevier United Kingdom. 2001.

12

12. Carel JC, Roger M, Ispas S, Tondu F, Lahlou N, Blumberg J, Chaussain J. Final Height after Long-Term Treatment with Triptorelin Slow Release for Central Precocious Puberty:Importance of Statural Growth after Interruption of Treatment. J Clin Endocrinol Metab. 1999;84(6):1973-8.

13

13. Mul D, Oostdijk W, Otten BJ, Rouwé C, Jansen M, et al. Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience. J Pediatr Endocrinol Metab. 2000;13 Suppl 1:765-72.

14

14. Lazar L, Kauli R, Pertzelan A, Phillip M. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height. J Clin Endocrinol Metab. 2002;87(5): 2090-4.

15

15. Partsch CJ, Hümmelink R, Peter M, Sippell WG, Oostdijk W, Odink RJ, et al. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty influence on growth and predicted adult height. Horm Res. 1993;39:111-7.

16

16. Carel JC, Lahlou N, Guazzarotti L, Joubert -Collin M, Roger M, Colle M, et al. Treatment of central precocious puberty with depot leuprorelin. French Leuprorelin Trial Group. Eur J Endocrinol. 1995;132:669-704.

17

17. Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR. Consensus statement on the use of gonadotropin releasing hormone analogs in children. Pediatrics. 2009;123:e752-62.

18

18. Mul D, Hughes IA. The use of GnRH agonists in precocious puberty. Eur J Endocrinol. 2008;159:S3-8.

19

19. 丁玲, 錢峻. 中醫藥治療女童性早熟槪況. 新中醫. 2004;36(2):74-75

  • Downloaded
  • Viewed
  • 0KCI Citations
  • 0WOS Citations

Other articles from this issue

Recommanded Articles

상단으로 이동

Journal of Korean Medicine